Ken Schneider

Ken Schneider is a seasoned sales professional with extensive experience in the oncology and molecular diagnostics sectors. Currently serving as a Regional Oncogenomic Liaison at Exact Sciences since January 2020, Ken has previously held key roles including Account Executive at Biocartis, where responsibilities included the sale of the Idylla platform to medical centers, and Regional Sales Manager at Cynvenio Biosystems, Inc. Notably, as Sales Director at Signal Genetics, Ken was instrumental in launching and commercializing a novel gene expression profile for Multiple Myeloma. With a strong track record of achievements, Ken earned several accolades including President's Club and top rankings in various roles, which underscores a commitment to delivering results in competitive markets. Ken holds a BA from the University of Arizona.